Hypertonic Saline, Mannitol and Hydroxyethyl Starch Preconditioning of Platelets Obtained From Septic Patients Attenuates CD40 Ligand Expression In Vitro

被引:6
作者
Huang, Go-Shine [2 ]
Shih, Chien-Ming [3 ]
Wu, Chin-Chen [4 ]
Hu, Mei-Hua [5 ]
Tsai, Chien-Sung [6 ]
Liaw, Wen-Jinn [2 ]
Chan, Shun-Ming [2 ]
Li, Chi-Yuan [1 ]
机构
[1] China Med Univ Hosp, Dept Anesthesia, Pain Serv & Crit Care Med, Taichung 40447, Taiwan
[2] Triserv Gen Hosp, Natl Def Med Ctr, Dept Anesthesiol, Taipei, Taiwan
[3] Natl Def Med Ctr, Dept Trop Med & Parasitol, Taipei, Taiwan
[4] Natl Def Med Ctr, Dept Pharmacol, Taipei, Taiwan
[5] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Div Pediat Crit Care & Emergency Med, Tao Yuan, Taiwan
[6] Triserv Gen Hosp, Div Cardiovasc Surg, Natl Def Med Ctr, Taipei, Taiwan
来源
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE | 2010年 / 68卷 / 02期
关键词
CD40L; Sepsis; Platelet; Hypertonic saline; Mannitol; Hydroxyethyl starch; INTRACELLULAR CALCIUM; RESUSCITATION; THERAPY; SEPSIS;
D O I
10.1097/TA.0b013e3181a6028e
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: Because platelet CD40 ligand (CD40L) expression plays an important role in inflammatory conditions, reduction of CD40L expression may be beneficial for patients with sepsis. Although hypertonic saline, mannitol, and hydroxyethyl starch (HES) solutions have been shown to modulate inflammatory responses, their effects on platelet CD40L expression are unclear. We assessed the effects of hypertonic saline, mannitol, and HES solutions on platelet CD40L expression. Methods: Platelet-rich plasma samples were obtained from septic patients and diluted to 1%, 2.5%, 5%, or 7.5% (vol/vol) with 7.5% saline, 3% saline, 0.9% saline, 20% mannitol, 10% HES (200/0.5), or Ringer's solution. Twenty-five samples were used per dilution. To determine platelet CD40L expression, platelet samples were stimulated with thrombin (0.1 U/mL), incubated with fluorochrome-conjugated platelet antibodies, and analyzed using flow cytometry. Results: Preconditioning of platelet-rich plasma with hypertonic saline, mannitol, and HES attenuated CD40L expression at dilution ratios of 5%, 1%, and 1%, respectively. The decreases were concentration dependent. The effects of mannitol and HES on CD40L expression were almost identical and were superior to those of 3% saline. In contrast, 0.9% saline and Ringer's solution had no effect on CD40L expression. Conclusions: Our data show that resuscitation fluids, Such as hypertonic saline, mannitol, and HES, inhibit agonist-induced CD40L expression on platelets. These resuscitation fluids may have an anti-inflammatory action when administered to septic patients.
引用
收藏
页码:331 / 336
页数:6
相关论文
共 36 条
[1]  
Adelson P David, 2003, Pediatr Crit Care Med, V4, pS12
[2]   Scientific and therapeutic advances in antiplatelet therapy [J].
Bhatt, DL ;
Topol, EJ .
NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (01) :15-28
[3]   DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ .
CHEST, 1992, 101 (06) :1644-1655
[4]   Intensive insulin therapy and pentastarch resuscitation in severe sepsis [J].
Brunkhorst, Frank M. ;
Engel, Christoph ;
Bloos, Frank ;
Meier-Hellmann, Andreas ;
Ragaller, Max ;
Weiler, Norbert ;
Moerer, Onnen ;
Gruendling, Matthias ;
Oppert, Michael ;
Grond, Stefan ;
Olthoff, Derk ;
Jaschinski, Ulrich ;
John, Stefan ;
Rossaint, Rolf ;
Welte, Tobias ;
Schaefer, Martin ;
Kern, Peter ;
Kuhnt, Evelyn ;
Kiehntopf, Michael ;
Hartog, Christiane ;
Natanson, Charles ;
Loeffler, Markus ;
Reinhart, Konrad .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (02) :125-139
[5]   Cellular response to hyperosmotic stresses [J].
Burg, Maurice B. ;
Ferraris, Joan D. ;
Dmitrieva, Natalia I. .
PHYSIOLOGICAL REVIEWS, 2007, 87 (04) :1441-1474
[6]  
Danese S, 2005, CRIT REV IMMUNOL, V25, P103
[7]   Small volume of hypertonic saline as the initial fluid replacement in experimental hypodynamic sepsis [J].
del Pilar Gallardo Garrido, Alejandra ;
Cruz Junior, Ruy Jorge ;
Poli de Figueiredo, Luiz Francisco ;
Rocha e Silva, Mauricio .
CRITICAL CARE, 2006, 10 (02)
[8]   The effects of high molecular weight hydroxyethyl starch solutions on platelets [J].
Deusch, E ;
Thaler, U ;
Kozek-Langenecker, SA .
ANESTHESIA AND ANALGESIA, 2004, 99 (03) :665-668
[9]   The use of hypertonic saline in the treatment of traumatic brain injury [J].
Doyle, JA ;
Davis, DP ;
Hoyt, DB .
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2001, 50 (02) :367-383
[10]   The effects of hydroxyethyl starches of varying molecular weights on platelet function [J].
Franz, A ;
Bräunlich, P ;
Gamsjäger, T ;
Felfernig, M ;
Gustorff, B ;
Kozek-Langenecker, SA .
ANESTHESIA AND ANALGESIA, 2001, 92 (06) :1402-1407